Feedback PLC (LON:FDBK), the specialist medical imaging technology company, has received a number of new significant orders for TexRAD technology.
The orders for its patented image texture analysis technology have been placed by prestigious university hospitals across Europe, including the first orders from universities in Belgium and Portugal.
READ: Feedback receives order for its TexRAD imaging technology for the Samsung Medical Centre in Seoul
Specifically, the TexRAD orders have come from Universitair Ziekenhuis Gent, Belgium; Beaujon Hospital, University Hospital Clichy, Service d'Imagerie médicale, France; ICNAS Producao Unip. Lda (Coimbra), Portugal; and University of Cagliari - Department of Diagnostic Imaging and Radiology, Italy.
The orders have arisen from an increase in business development activities during the year, Feedback said. These include scientific presentations and peer group referrals from previous purchasers of TexRAD.
Picture from the exhibition stand at The 34th Annual Meeting of the Korean Society for Radiation Oncology in Seoul, South Korea today! #TexRAD https://t.co/P67kvnkepP #Cancer #Oncology #Radiology #textureanalysis #Radiomics #TexRAD #FBKmed #FridayFeeling @balajiganeshan pic.twitter.com/phq8vjl2NV
— Feedback Medical Ltd (@FBKmed) October 12, 2018
"These recent orders of TexRAD are further validation of Feedback Medical and our technology,” said Dr Balaji Ganeshan, global business development director of Feedback Medical Lts.
“We are taking advantage of our growing reputation to drive new business. These new business wins have resulted from having referrals from current customers and penetrating new country markets. TexRAD is now being used in a diverse range of research fields which demonstrates the significant potential and applicability of our technology," he added.
Shares in Feedback were up 2.9% at 1.8525p.